Antimicrobial resistanceWe believe a one health approach is needed across human medicine, veterinary practice and agriculture to tackle the threat of antimicrobial resistance (AMR).
Childhood immunisationDoctors have expressed concern about declining coverage rates for childhood vaccinations in some areas of the UK, and the potential for this to lead to outbreaks of disease.
Child and young people's healthThe BMA has a longstanding interest in child health and the impact of social inequalities on health outcomes for children and young people.
Growing up in the UK: ensuring a healthy future for our childrenOur keystone report concluded that we are failing our most vulnerable children, and expressed major concerns about the effects of poverty and social inequalities on child health and wellbeing in the UK.
Growing up in the UK 2016 reviewThree years on from our 2013 report, we undertook a review of the developments in child health since its publication.
Autism spectrum disorderIt is estimated that around 700,000 people in the UK have a diagnosis of autism. One in 100 children in the UK have a diagnosis of autism spectrum disorder. We have raised concerns about the time it takes for diagnosis, as well as specific issues with the support offered in England.
Cutting away at our children’s futures: how austerity is affecting the health of children, young people and familiesA report focusing on the impact of austerity and welfare reforms on children, young people and families.
Supporting a healthy childhood: the need for greater investment in servicesA safe, supportive and happy childhood environment is widely understood to be vital for a child's development, health and wellbeing over the short- and long-term.
Drivers of ill health
Improving the nation’s diet: action for a healthier futureTo effectively respond to the public health challenge of diet-related ill health, a range of actions are required across the UK.
Reducing alcohol-related harm in EnglandA wide-ranging approach to reducing alcohol-related harm is needed covering the availability, affordability and marketing of alcohol as well as support for healthcare professionals.
Alcohol and pregnancy: preventing and managing fetal alcohol spectrum disordersIn an update to our 2007 report, we outline the responsibilities of healthcare professionals and policy makers to improve the prevention, diagnosis and management of fetal alcohol spectrum disorders.
E-cigarettes: balancing risks and opportunitiesThis paper discusses the regulation of e-cigarettes and argues for an approach that seeks to minimise their risks while maximising their potential to reduce the health burden associated with smoking.
TobaccoThe BMA has a long history supporting measures to reduce tobacco-related harm and have wide-ranging policies aimed at strengthening tobacco control and helping smokers to quit.
Climate change and air pollution
Tackling air pollution and climate change is vital for protecting some of the most vulnerable in society, while also reducing the burden on health services.
Health at a price: reducing the impact of povertyWithin the healthcare setting, action can be taken in a range of ways to help reduce the impact on health, and doctors can play a key role in supporting action in this area.
Health in all policies: health, austerity and welfare reformThis briefing aims to support doctors’ advocacy role in protecting health during times of austerity, setting out the potential harms to health of austerity and the action needed to prevent them occurring.
Improving immunisation coverage rates across the UK
The BMA strongly supports vaccination programmes as a key intervention for improving population health. Read our view on what action is needed to improve coverage rates.
Beyond parity of esteem reportAchieving parity of resource, access and outcome for mental health in England
The impact of COVID-19 on mental health in England
Our paper outlines the effects of the COVID-19 outbreak on population mental health and calls for improvements to mental health services to ensure they can respond to needs of the population.
Prescription and illicit drugs
Cannabis-based medicinal productsWhat constitutes cannabis-based products for medicinal use, who can prescribe them, and under what circumstances.
Chronic pain: supporting safer prescribing of analgesicsThis briefing paper was first published in 2017 and highlights some of the key issues surrounding the use of analgesics in the management of patients with chronic pain.
Improving analgesic use to support pain management at the end of lifeThis briefing focuses on promoting adequate access to pain relief for patients at the end of life, including exploring the attitudes of doctors and patients towards the prescribing of strong analgesics to control pain.
Drugs of dependence - the role of medical professionalsThis report was first published in 2013 and seeks to open and refocus the debate on drug treatment and drug policy through the eyes of the medical profession.
Prescribed drugs associated with dependence and withdrawal
Prescribing of psychoactive drugs is a major clinical activity and a key therapeutic tool for influencing the health of patients. But often their use can lead to a patient becoming dependent or suffering withdrawal symptoms.